Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$7.10 – $14.50
100% from low
No one on the platform currently holds FOLD.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,872,893 | $27.1M |
No one on the platform has traded FOLD yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $754M | +19.6% | $0.36 | $0.35–$0.37 | 40.6× | 1 |
| 2027 | $896M | +18.9% | $0.64 | $0.61–$0.67 | 22.6× | 3 |
| 2028 | $1.1B | +22.2% | $0.91 | $0.85–$0.97 | 15.9× | 2 |
| 2029 | $1.3B | +19.3% | $1.36 | $1.32–$1.40 | 10.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-20 | $0.07 | $0.01 | -86.0% |
| 2025-11-04 | $0.12 | $0.17 | +41.7% |
| 2025-07-31 | $0.02 | $0.01 | -50.0% |
| 2025-05-01 | $0.08 | $0.03 | -62.5% |
| 2025-02-19 | $0.02 | $0.09 | +350.0% |
| 2024-11-06 | $0.08 | $0.10 | +25.0% |
| 2024-08-08 | $0.05 | $0.06 | +9.8% |
| 2024-05-09 | $-0.06 |
| $-0.02 |
| +66.7% |
| +0.00% |
| $3.9B |
| — |
| IDYAIDEAYA Biosciences, Inc. | $36.68 | -0.76% | $3.5B | — |
| KNSAKiniksa Pharmaceuticals International, plc | $77.83 | -0.41% | $5.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
$ALT $APGE $FOLD $TECH $TERN So, in your Tern chart, short interest increased over a 6 month period by 1.5-2.5 times its SI 6 months earlier. Wow. Then hit Not fairy tale gobbledygook. Legitimate. Market. Analysis. 👏👏👏👏👏👏👏👏👏👏
View on StockTwits ↗$ALT $APGE $FOLD $TECH Short interest of $TERN kept growing and were running into Merck s BO- Offer on March 25 😉👇
View on StockTwits ↗$ALT $APGE $FOLD $TECH Trade, interesting thoughts on WHY we see rising short interest and an increase in Bashers ahead of BO news…
View on StockTwits ↗$ALT $APGE $FOLD $TECH What I can tell you without any more dd, Dilution is not uncommon before a deal. Basta!
View on StockTwits ↗$ALT $TECH $APGE $FOLD interesting. Have you matched it with the available shares of those companies? Maybe it's just that they diluted too and mire available shares meant more shorting? Or dilution means upcoming buyout?
View on StockTwits ↗$ALT $APGE $FOLD $TECH Trade, that’s a HELLUVA find. Great job man….🙏🙏😎😎
View on StockTwits ↗$ALT Regarding the question about growing short interest: I’ve noticed several times that short interest increased significantly and kept rising right up until the buyout of certain biotech companies. I asked ChatGPT to list the major biotech buyouts in 2026. The results are $TECH, $APGE, and $FOLD. Interestingly, all of them showed elevated or growing short interest leading up to the acquisition announcement. 👇
View on StockTwits ↗@TGTT888 dont forget Biomarin , they bought $FOLD for their Fabry ERT !!!!
View on StockTwits ↗$FOLD reported - EPS and - revenue for Q1. http://www.estimize.com/intro/fold?chart=historical&metric_name=eps&utm_content=FOLD&utm_medium=
View on StockTwits ↗$SOS $FOLD $AMPX $ONDS $TZOO
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.